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Speech:† Breast Cancer Advocacy and Public Policy 
Frances M. Visco∗ 
I. INTRODUCTION 
There is no better illustration of the intersection between law, 
politics and social justice than in the world of women’s health care 
advocacy. I was honored to have the opportunity to participate in this 
year’s Public Interest Law Speakers Series to explain how my law 
training enhanced my career in breast cancer advocacy. This training 
enabled me to work to change the law, instead of merely working 
within it. 
The issue of breast cancer, and women’s health generally, is a 
political issue and requires an expanded approach to public interest 
law. Decisions that affect how individual women are treated—such as 
how much and what research is performed, whether the 
environmental connections to breast cancer are understood and dealt 
with, whether all women will have access to quality health care—are 
made at the political level. Appropriations for breast cancer research 
come from Congress. Congress tells the Food and Drug 
Administration (FDA) what to do, and the FDA approves drugs and 
devices.2 Government-regulated programs, such as Medicaid and 
Medicare, provide access to health care for many individuals in this 
country. Even private insurance companies are regulated by the 
states.  
 † Delivered at Washington University School of Law on February 16, 2005. Minimal 
footnotes have been added by the author. 
 ∗ Antitrust attorney and partner in a Philadelphia law firm until diagnosed with breast 
cancer seventeen years ago, she was named president of the National Breast Cancer Coalition in 
1991, the first and only person to hold this position. This Article is based on a presentation by 
Ms. Visco in the Public Interest Law Speaker Series at Washington University School of Law 
on February 16, 2005. She wishes to acknowledge Romi Neustadt, J.D., for her assistance with 
this Article. 
 2. Food, Drug and Cosmetic Act, 21 U.S.C. §§ 301–97 (2000). 
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As a lawyer, I recognize that to have a significant impact on breast 
cancer—not just for individual women but on the systems that affect 
all women—the usual public interest law approach is not enough. 
Necessary, overarching change will not likely come about through 
the judicial system, a system that is bound by tradition and precedent. 
What breast cancer advocates realized in the early 1990s was the 
need to make new law to change the systems that affect everyone—
the systems of research, access to care and regulation. Fortunately, 
my background and education equipped me to meet the challenges of 
forging new law and refusing to settle for the status quo in the name 
of precedent. 
II. MY ROAD TO WOMEN’S HEALTH CARE ADVOCACY 
I have always been a political person interested in social justice. 
My first memory of what I wanted to pursue professionally was to 
become a medical missionary. Soon thereafter I decided I wanted to 
be a lawyer in order to right wrongs. While I worked my way through 
my undergraduate degree and law school, I actively volunteered for 
causes that were important to me. I was an anti-war activist in the 60s 
and early 70s and fought for women’s rights. And I have always 
regretted that I was born too late to be part of the peak of the civil 
rights movement.  
I went to law school somewhat late in life, at age thirty-two, and 
graduated in 1983. After many years focusing on issues of social 
justice, I went to work for a Philadelphia law firm in the commercial 
litigation department. I did so, however, because I knew I would have 
a mentor at the firm who volunteered time with the ACLU and had 
been involved in death penalty cases before the U.S. Supreme Court. 
My true mentor in the firm turned out to be another partner who 
taught me how to use the law to logically construct and prove a case, 
step-by-step; to tear it apart and then build it back up. Because of him 
I learned the importance of believing in your case, and that the focus 
should never be on my performance, but on the client and the client’s 
goals. Because of him, I learned that I should never walk into a 
courtroom without knowing every strength and weakness of my case, 
or every possible argument and rebuttal my opponent could make. 
While I knew I was receiving invaluable tools for my litigation 
https://openscholarship.wustl.edu/law_journal_law_policy/vol19/iss1/7
p 65 Visco book pages.doc  2/20/2006 
 
 
 
 
 
 
 
 
 
2005]  Breast Cancer Advocacy and Public Policy 67 
 
 
toolbox, I had no idea how truly indispensable this training would 
prove in my future role as a health care advocate.  
I might still be a partner in that law firm, handling antitrust 
litigation, sitting on nonprofit boards in my community and 
volunteering for political campaigns. But in September 1987, at the 
age of thirty-nine with a fourteen-month-old son, I was diagnosed 
with breast cancer. Between September and May of 1988, I 
underwent treatment—surgery, radiation and chemotherapy. I cut 
back slightly on my caseload and put my volunteer work on hold. 
When I went back to practice law in full force, I began to work with a 
local breast cancer group in Philadelphia. While the group filled the 
important role of helping individual women, I wanted to challenge 
the systems of research and care and become politically involved.  
Fortunately, in 1991, I was invited to a meeting that launched 
what was to become the National Breast Cancer Coalition (NBCC). 
The meeting gathered together a group of women who, like me, had 
been activists for other causes. We wanted to do for breast cancer 
what AIDS activists had done for AIDS.  
As an attorney on the first board of advisors to NBCC, the group 
initially looked to me for the typical role of lawyers on nonprofit 
boards such as advice in structuring the organization and 
incorporation. In addition, I was also able to bring to the discussion 
the framework that I had come to embrace when dealing with any 
case or cause: identifying the goal—how to define success—and then 
the step-by-step approach of building toward that ultimate goal by 
building an argument to sway the decision makers and making certain 
that you have the evidence to back it up. 
When I first started to receive calls from women around the 
country asking me to run for the position of the first president of 
NBCC, I remember telling them that I could not do it. I had a full 
practice and was just a volunteer. But they kept asking and finally I 
said what seems in retrospect the most ridiculous thing that I have 
ever uttered: “Okay, I will do it if you promise it will not interfere 
with my law practice.” Naturally, it took over my life. While I 
gradually convinced my partners that I could work part-time, 
ultimately they told me I had to make a choice—either come back as 
a full-time partner, or leave and run NBCC. In April 1995, I resigned 
my partnership. 
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III. THE LAWYER’S BAG OF TRICKS: USING LITIGATION SKILLS TO 
BUILD THE NATIONAL BREAST CANCER COALITION 
I was not giving up the law; rather, I was changing how I would 
work with it. I went from working within the judicial system—trying 
cases and representing individuals in class actions—to using the 
legislative and regulatory aspects of the law to change public policy 
and make law. I viewed breast cancer not as an individual fight or an 
individual health issue, but as a vital issue in the women’s health 
arena that had been ignored by the powers-that-be for too long. 
Breast cancer was a new social justice challenge that needed legal 
attention. 
I had sat in a conference room with a team from my law firm 
many times, laying out the elements of my client’s case. How would 
we define success? What did we need to prove to achieve our 
victory? What were the required steps, the necessary testimony and 
documentary evidence, and how would we assure that it would all be 
admissible? My legal training brought that same process and analysis 
to NBCC.  
We decided to define success as eradicating breast cancer. Yet, we 
did not know how to prevent breast cancer, how to detect it early 
enough, or how to cure it. What we did know was that to achieve 
success we had to focus on the systems of research and access to 
care. We had to make certain that we understood how to prevent and 
treat the disease. We also needed to ensure that all women had access 
to what was available. Of course, we needed increased funding for all 
of this.  
As breast cancer advocates, like trial attorneys, we needed to 
prove our case. To do so, it was imperative to determine what the 
decision-makers cared about. We did this by employing the skills 
learned from my litigation practice and my mentor. Through an 
analytical approach, we took apart each issue and reconstructed it, 
carefully considering every component, thinking critically, constantly 
questioning and considering how all the pieces fit together. We were 
relentless and courageous, took nothing at face value and questioned 
everyone’s motives and agendas. We knew that presenting our 
position with force and credibility would make others want to follow. 
https://openscholarship.wustl.edu/law_journal_law_policy/vol19/iss1/7
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To reach our goal of eradicating breast cancer, we had to make 
certain the research community had the necessary funds. We 
critically analyzed the research funding problem. Was more money 
actually needed or were adequate funds simply being allocated 
incorrectly? What would the right amount of money be, how could 
we find out, and who should we believe? While researchers will 
always tell you they need more money, the government typically 
argues that they are already getting enough. NBCC determined that to 
get the real answers to these questions and prove our case, we needed 
to do independent research and analysis and conduct our own 
research hearings.  
Based on this research, we determined that in 1992 the scientific 
community could spend an additional $300 million on breast cancer 
research—from its current level of $100 million to more than $400 
million.3 Congress did not embrace us or our numbers with open 
arms. While we knew it would take more than evidence to sway the 
decision-makers, we also understood that pressure from their 
constituents could force change. Accordingly, we began to grow and 
energize our national grassroots network. 
That was also the year I had my first opportunity to testify before 
Congress.4 I remember the day vividly. It was what I called “Disease 
Day” before the Senate Committee on Appropriations, and there were 
many people in line waiting to testify about their particular 
organization and why Congress should give them more money. I was 
the last in line. 
Each group made its plea. The messages were basically all the 
same: “We really appreciate what you have done for us in the past. 
Thank you so very much. If you could see your way through, we’d 
really appreciate it if you could give us a little more money this 
year.” I was not impressed. 
During the others’ testimony, I sat in the back of the room and 
listened intently. Looking around, I saw many breast cancer survivors 
in attendance, waiting anxiously. This was the monumental beginning 
 3. Departments of Labor, Health and Human Services, and Education, and Related 
Agencies Appropriations, FY 93: Hearing Before the S. Comm. on Appropriations, 102d Cong. 
487-92 (1992) (statement of Frances M. Visco, President, National Breast Cancer Coalition). 
 4. Id. 
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of our movement. As a trained litigator, I knew I could not address 
the committee, hat in hand, and merely ask for money; I had to make 
my case, argue my position and persuade the members to change 
their behavior. I also needed to speak directly to the advocates in the 
room in order to convince them that we had chosen the correct 
political path. When it was finally my turn, I discarded my prepared 
remarks and walked up to the microphone.  
“I’m here to tell you that women have declared war on breast 
cancer,” I said. “You have found billions of dollars to fund the 
Persian Gulf War. You have found billions of dollars to fund and bail 
out the savings and loan industry, which was destroyed by men in 
suits. You can find $300 million more to save women’s lives. And 
I’m here to tell you that we won’t go away until you do.”5  
While that was a call to action, it was also powerful and 
persuasive because we had prepared our case and could back it up. 
With a great deal of focus and hard work, we educated our grassroots 
network and trained them in not only the science of breast cancer, but 
also how to use the political process to be good advocates. They 
inundated Congress with our messages, and every year our network 
of advocates returns to Congress and demands continuation of 
funding. To date, NBCC has brought nearly two billion new dollars 
to breast cancer research from the defense budget alone, but that’s a 
story for another article.  
IV. FROM RESEARCH TO ACCESS TO CARE 
A recent Harvard University study indicates that half of personal 
bankruptcies in the U.S. (two million individuals) are the result of 
illness or medical bills.6 Shockingly, three-quarters of those who 
declared bankruptcy had health insurance. With forty-six million 
Americans uninsured, the situation clearly requires a legislative fix 
and screams out for public interest lawyers to get involved to fix the 
systems of access to healthcare.7 
 5. David U. Himmelstein et al., MarketWatch: Illness and Injury as Contributors to 
Bankruptcy, HEALTH AFF. (2005), http://www.healthaffairs.org. 
 6. Id. (analyzing data from the Consumer Bankruptcy Project). 
 7. KAISER FAMILY FOUND., KAISER COMM’N ON MEDICAID AND THE UNINSURED, THE 
UNINSURED: A PRIMER (2004), available at http://www.kff.org/uninsured/7216.cfm. 
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At its inception, NBCC did not take on the entire health care 
system. Yet after we tackled the research funding issue, we turned to 
access to care. In 1991, we were faced with a law that Congress had 
passed that required the government to fund screening, mammograms 
and pap smears for uninsured women.8 These women are typically 
the working poor, uninsured or underinsured, with incomes at 
approximately 200 percent of the poverty level. Despite their low 
income, they earn too much to qualify for Medicaid. While the 
screening act would diagnose cancer, there was no provision to treat 
the disease if it was detected. These women were left to a rapidly 
deteriorating system of charity care and, while they could have gone 
to public interest law firms and programs for individual help, there 
was no law to apply and no precedent to argue. 
NBCC analyzed the issue of screening for breast cancer without 
treatment and researched what public policy approach would be best. 
Logically, it appeared that moving these women into an existing 
system would be far superior to creating a totally new system of 
access. Our goal was to construct legislation that would make these 
women eligible for Medicaid for all of their health care needs.  
Congress responded that these women could be helped through 
the charity care system. Therefore, we knew we needed evidence of 
the extent of the problem and why reliance on charity care was not 
enough. Again, we conducted independent research and analysis and 
presented data to Congress to prove why the charity care system was 
a failure, and our pressure brought about a Congressional hearing on 
the issue.9 To testify to the extent of the problem, we identified and 
brought in physicians who helped with charity care and patients who 
had been screened through the system but were not treated. We also 
conducted forums to educate Congress and made our case to the 
administration. We trained our grassroots lobbyists to understand all 
the possible arguments and what the answers were. Slowly, we 
moved the bill through the system. Finally, after more than four 
years, we achieved success, and today a system of care for thousands 
 8. The Breast and Cervical Cancer Mortality Prevention Act of 1990, Pub. L. No. 101-
354, 104 Stat. 409. 
 9. The Breast and Cervical Cancer Prevention and Treatment Act of 1999, H.R. 1070, 
106th Cong. (1999). 
Washington University Open Scholarship
p 65 Visco book pages.doc  2/20/2006 
 
 
 
 
 
 
 
 
 
72 Journal of Law & Policy [Vol. 19:65 
 
 
 
of uninsured women in this country exists through legislation in the 
public interest—all because of grassroots advocacy.10 
There are constant assaults on the public interest that take many 
forms, and NBCC, like any advocacy group, cannot afford to lose 
focus. For example, decision-makers will often appear to devise a 
right in response to advocacy, but it will be devoid of a remedy. It 
happens more and more as issues such as tort reform get more 
attention. When we tackled the issue of genetic discrimination, we 
had to deal with this exact problem. 
We were working on a national level to have a law introduced that 
would protect all individuals from genetic discrimination on the basis 
of predisposition to disease. On a state-by-state basis, our advocates 
were working to get state laws passed that would prohibit this 
discrimination in health insurance and employment. Our group in 
Virginia was incredibly proud of a bill enacted in that state that 
would actually afford those protections.11 When we looked at the 
legislation on the national level, however, we realized that there were 
no enforcement provisions, so there was no way to give the 
legislation true meaning.  
Accordingly, we began developing policies of inclusion of 
enforcement provisions in all legislation that we supported. We 
educated our grassroots advocates around the country about the 
importance of that approach, and made certain that all of the laws that 
they were working on in their respective states contained strong 
enforcement provisions. It is this type of focus that NBCC has 
brought to advocacy and grassroots efforts, in large part, I believe, 
because of my legal background and the background of other leaders 
in this movement.  
I have testified before Congress a number of times on the need for 
meaningful enforcement in any legislation that confers rights. One of 
my favorite occasions was an invitation by the House Commerce 
Subcommittee on Health and Environment to testify at a hearing 
entitled Barriers of Access to Quality Care for Patients that covered 
tort reform and malpractice caps. When I spoke, I asked the 
 10. The Breast and Cervical Cancer Prevention and Treatment Act of 2000, Pub. L. No. 
106-354, 114 Stat. 1381. 
 11. Genetic Information Privacy Act, VA. CODE ANN. § 38.2-508.4 (2005). 
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subcommittee: If we are truly interested in removing barriers to 
access to care, why are we not speaking about guaranteeing access to 
health insurance and health coverage for all Americans? Why are we 
beginning the discussion with punishing the patients?12  
V. THERE IS SUCH A THING AS BAD ADVOCACY 
Unfortunately, bad advocacy exists. One example is a piece of 
legislation touted by a number of groups and individuals around the 
country. The “Drive-through Mastectomy Bill” that some advocates 
have designed would require insurance companies to cover in-
hospital stays for at least forty-eight hours after a woman has had a 
mastectomy.13 It sounds very compelling, and millions of individuals 
have signed the petition to support the legislation. Yet it is stalled on 
Capitol Hill in large part because it does not have the support of 
NBCC.  
The legislation is bad public policy, and we determined this by 
applying the process we honed in breast cancer advocacy to analyze 
the legislation. What are the goals of the legislation? Is it really 
needed? What is the evidence behind it? How would we define 
success? We quickly determined that the science does not support the 
mandatory hospital stay approach. Evidence from multiple studies14 
has established that medical outcomes are equally good after 
outpatient mastectomies as after hospital stays. In addition, rather 
than trying to reform the health care system one benefit at a time, 
what we need to do is focus Congress on reforming the entire health 
care system.  
As responsible grassroots advocates, we recognize that by 
critically examining these policies, we are able to see the flaws. We 
cannot simply react to problems defined by others. We must all 
 12. Harming Patient Access to Care: The Impact of Excessive Litigation: Hearing Before 
the H. Comm. on Energy and Commerce, 107th Cong. (2002) (written statement of Francis M. 
Visco, President, National Breast Cancer Coalition). 
 13. Breast Cancer Patient Protection Act of 2003, S. 1684, 108th Cong. (2003); Breast 
Cancer Patient Protection Act of 2003, H.R. 1886, 108th Cong. (2003). 
 14. Anthony A. Goodman & Armando L. Mendez, Definitive Surgery for Breast Cancer 
Performed on an Outpatient Basis, 128 ARCHIVES SURGERY 1149 (1993); Richard G. 
Margolese & Jean-Claude M. Lasry, Ambulatory Surgery for Breast Cancer Patients, 7 
ANNALS SURGICAL ONCOLOGY 181, 181–87 (2000). 
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question and analyze what is the correct approach. NBCC has created 
a model that has been replicated by many other groups. Earlier this 
year, we were identified in a study that was published in The Hill, a 
newspaper about Congress. The study, a survey of congressional staff 
members conducted by a University of Chicago professor, identified 
NBCC as one of the top twenty groups that influence national health 
policy.15 The other organizations on the list were incredibly powerful, 
well-funded organizations, such as the American Medical 
Association and the Pharmaceutical Manufacturers Association of 
America. This is impressive recognition for our grassroots network of 
organizations that is barely fourteen years old. I believe we made the 
list because of our approach to responsible advocacy and because we 
have never been afraid to be controversial. Indeed, NBCC’s agenda is 
often controversial. For example, our view that trained advocates 
belong in power positions and should have a seat at the table where 
decisions are made is controversial. But we are about change, and 
when you are challenging entrenched systems, there will always be 
controversy.  
VI. CONCLUSION 
While legal training is not necessary for effective public 
advocacy, it is an invaluable preparation. NBCC has brought billions 
of new dollars for breast cancer research and systems of access to 
care for thousands of underserved women by recognizing that breast 
cancer is a public interest issue. It is an issue that, with legal training 
and skill, we have brought to the forefront of the political agenda in 
this country. 
Someone very dear to me, Millie Jeffrey, the Democratic activist, 
said shortly before her death: 
I believe in individual initiative. In other words, that each of us 
has a responsibility to take some action as an individual in our 
own part. But I also know that unless that is brought together 
in collective action in a group working together, in a group 
 15. See Top 25 “Influential Groups in Health Policy” Based on Interviews with 
Congressional Staffers, HILL (Wash. D.C.), October 1, 2003.  
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agreeing on goals and objectives and then implementing those, 
that you are not going to produce change. And, I suppose, 
change is what I believed in all my life.16 
We all recognize that the law is the greatest instrument for 
change. Regardless of the path you choose after law school, I 
encourage you to find a meaningful cause in which you believe and 
volunteer or make it part of your daily work. And remember, there 
are many possible paths. I am proof of that. 
 16. Interview by Tom Downs with Mildred Jeffrey, Political Activist, in Okemos, Mich., 
(1995), reprinted in Adam Bernstein, Mildred Jeffrey, 93; Fought for Social, Political Justice, 
PHILLY.COM, Mar. 29, 2004. 
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